Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.
The prolonged and intricate history of oncological treatments has transitioned significantly since the introduction of chemotherapy. Substantial therapeutic benefits in cancer therapy have been achieved by the integration of conventional treatments with molecular biosciences and omics technologies. Human epidermal growth factor receptor, hormone receptors, and angiogenesis factors are among the established therapies in tumor reduction and managing side effects. Novel targeted therapies like KRAS G12C, Claudin-18 isoform 2 (CLDN18.2), Trophoblast cell-surface antigen 2 (TROP2), and epigenetic regulators emphasize their promise in advancing precision medicine. However, in many cases, the resistance mechanisms associated with these interventions render them ineffective in carrying out their functions. The purpose of this review is to provide a comprehensive and up-to-date examination of both established and emerging drug targets and mechanisms of treatment resistance in oncology. This review seeks to elucidate recent advancements, address persisting challenges, and explore opportunities for innovative developments in cancer target research. Additionally, it explores the growing role of artificial intelligence in reshaping cancer drug discovery and development frameworks as potential avenues for future research. In conclusion, innovative approaches in oncology, supported by pharmacological research, ongoing clinical trials, molecular biosciences, and artificial intelligence, are poised to significantly transform cancer treatment.
Due to their advantageous physicochemical properties, metabolic stability, and bioisosterism with carboxylic acid and amide groups, tetrazole derivatives represent a valuable class of heterocycles that play a crucial role in medicinal chemistry and drug development. Advances in chemistry have enabled the versatile synthesis of tetrazole-based compounds. Therefore, optimizing the potential of tetrazoles to produce lead compounds requires effective synthetic access to a wide range of derivatives. According to the published papers, there are several methods for preparing tetrazole and its mono- and disubstituted derivatives, including 5-substituted 1H-tetrazoles, 2-substituted 1H-tetrazoles, 2,5- and 1,5-disubstituted, fused heterocycles, tetrazole derived hybrid azaheterocycles, etc. The use of tetrazoles as ligands, in bridging roles, in multiple tetrazole syntheses, and in other heterocyclic ring forms is also demonstrated. Alkylation, nucleophilic and electrophilic substitution in the side chain, electrophilic substitution at the ring carbon atom, and the effect of the reagents used are among the chemical characteristics of tetrazoles that are investigated. This mini-review also examines synthetic processes and discusses their benefits and drawbacks in this field of study.
The isolation of Azithromycin in Azithromycin Powder for oral suspension using liquid-liquid extraction, development of stability-indicating method followed, an analytical method validation using HPLC for quantification of probable impurities of Azithromycin in Azithromycin for oral suspension. The ccritical separation between impurities after isolation from sample matrix of the drug product is achieved on X Bridge® C18, 5µ, 250 x 4.6mm column. pH 9.5 disodium Phosphate buffer (20mM) is phase A, acetonitrile and methanol in the ratio 75:25v/v is phase B in gradient elution. The flow is maintained at 1.0 mL/min, 210nm was fixed for quantification purpose at 60°C. Method is validated as per ICH recommended parameters. HPLC method is highly beneficial for determination of impurities of Azithromycin in Azithromycin for oral suspension. Liquid-liquid extraction eliminates the intervention of the complex placebo peaks which interferes with impurities related to Azithromycin.
Monitoring systems for autonomous vehicles are increasingly critical for both safety-critical applications and intelligent transportation systems; however, existing methodologies have some deficiencies, including perceptiondecision latency mismatches, lack of immersive multi-object semantic understanding, and absence of predictive capabilities. The current issues will be addressed using a Cognitive Vision-Guided Dual-Loop Monitoring System (CV-DLMS), which encompasses real-time perception and predictive decisionmaking. To accomplish this, multi-modal visual data will first be captured and preprocessed using noise reduction and normalization techniques, followed by an improved genetic algorithm to optimize the selected features via feature optimization. Semantic-aware detection and tracking modules will then be applied to detect and track multiple objects in a semantically aware context. Additionally, an intelligent fast loop and a predictive slower loop utilizing Kalman filtering and temporal modeling to predict future states and provide risk assessments form a key part of the proposed approach. Finally, adaptive decision output will be produced according to predicted conditions to provide a proactive and steady monitoring solution. Experimental evaluations established that the proposed CV-DLMS method provides superior detection accuracy of 95.5%, tracking precision of 96.8% and root mean square error of 0.76, which has greater prediction reliability than traditional methods and, thus, can be deployed effectively in real-time autonomous vehicle monitoring systems.
